Antitumoral Agent-Induced Constipation: A Systematic Review.

Agnès Calsina-BernaJesús González-BarboteoSilvia Llorens-Torromé Joaquim Julià-Torras

Published in: Cancers (2023)

The prevalence of constipation in patients undergoing antitumoral treatment is very diverse. Studies specifically designed to report the prevalence of antineoplastic treatment-induced constipation are needed. The importance of enteric neuronal integrity in gastrointestinal function was described. Thus, neuroprotection could be an area of research for the treatment of chemotherapy-induced gastrointestinal disorders.

Keyphrases

patients undergoing
risk factors
combination therapy
irritable bowel syndrome
brain injury
oxidative stress
drug induced
cerebral ischemia